|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 20/21/20 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 22/20/22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 01/01/2020 |
Patty Meehan
ADM | Chief Administrative Officer | - | 01/01/2002 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 01/08/2015 |
Sally L. Maher
BRD | Director/Board Member | - | 01/05/2019 |
| Director/Board Member | 71 | 01/07/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 34Cr | |
| +1.16% | -1.13% | -18.25% | +9.38% | 18TCr | |
| +0.02% | +4.24% | -19.55% | +15.88% | 12TCr | |
| -1.22% | +0.70% | +1.86% | +32.59% | 12TCr | |
| +2.29% | +17.36% | -42.18% | +8.22% | 9.33TCr | |
| -2.21% | -2.91% | -0.51% | +75.12% | 6.32TCr | |
| -1.06% | +1.75% | +13.48% | +74.12% | 5.57TCr | |
| -0.75% | +3.73% | +7.04% | -23.26% | 5.42TCr | |
| -1.13% | +0.00% | -12.56% | +30.09% | 4.41TCr | |
| +0.17% | +5.85% | -5.20% | -11.43% | 3.4TCr | |
| Average | -0.27% | +3.24% | -8.43% | +23.41% | 7.59TCr | |
| Weighted average by Cap. | -0.00% | +3.09% | -11.77% | +21.99% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 8.92Cr 7.97Cr 7.36Cr 6.67Cr 12Cr 846.97Cr 13Cr 89Cr 35Cr 443.76Cr 33Cr 33Cr 1.4TCr | 10Cr 9Cr 8.32Cr 7.54Cr 14Cr 956.83Cr 14Cr 100.06Cr 40Cr 501.32Cr 38Cr 37Cr 1.58TCr |
| Net income | -31.31L -27.96L -25.83L -23.41L -43.8L -30Cr -44.52L -3.11Cr -1.23Cr -16Cr -1.18Cr -1.15Cr -49Cr | 14.49L 12.94L 11.95L 10.83L 20.26L 14Cr 20.6L 1.44Cr 56.94L 7.21Cr 54.37L 53.21L 23Cr |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
